NeuroPace (NPCE) Shares Outstanding (2020 - 2026)

NeuroPace has reported Shares Outstanding for 7 years, with the latest figure at $33.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 3.54% year-over-year to $33.9 million; the trailing twelve-month figure through Mar 2026 stood at $33.9 million (up 3.54% YoY), and the FY2025 full-year result was $33.6 million, up 11.38% from the prior year.
• Shares Outstanding for Q1 2026 stood at $33.9 million, up from $33.6 million in the prior quarter.
• The five-year high for Shares Outstanding was $33.9 million in Q1 2026, with the low at $24.5 million in Q1 2022.
• Average Shares Outstanding over 5 years is $28.8 million, with a median of $28.7 million recorded in 2024.
• Peak annual rise in Shares Outstanding reached 5100.89% in 2022, while the deepest fall reached 2.14% in 2022.
• Tracing NPCE's Shares Outstanding over 5 years: stood at $25.0 million in 2022, then increased by 11.09% to $27.8 million in 2023, then gained by 8.34% to $30.1 million in 2024, then climbed by 11.38% to $33.6 million in 2025, then advanced by 1.0% to $33.9 million in 2026.
• The last three Shares Outstanding figures came in at $33.9 million (Q1 2026), $33.6 million (Q4 2025), and $33.3 million (Q3 2025), per Business Quant data.

Peer Comparison